5-Amino-3,4-dimethylisoxazole → N-(3,4-dimethylisoxazol-5-yl)-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide

HRID 1666327

反応式

HRID 1666327 の反応式
Cl.[NH:2]1[CH2:7][CH2:6][C:5](=[CH:8][C:9]2[CH:10]=[C:11]([CH:23]=[CH:24][CH:25]=2)[O:12][C:13]2[CH:18]=[CH:17][C:16]([C:19]([F:22])([F:21])[F:20])=[CH:15][N:14]=2)[CH2:4][CH2:3]1.[CH3:26][C:27]1[C:31]([CH3:32])=[C:30]([NH:33][C:34](=O)[O:35]C2C=CC=CC=2)[O:29][N:28]=1.NC1ON=C(C)C=1C>>[CH3:26][C:27]1[C:31]([CH3:32])=[C:30]([NH:33][C:34]([N:2]2[CH2:7][CH2:6][C:5](=[CH:8][C:9]3[CH:25]=[CH:24][CH:23]=[C:11]([O:12][C:13]4[CH:18]=[CH:17][C:16]([C:19]([F:22])([F:20])[F:21])=[CH:15][N:14]=4)[CH:10]=3)[CH2:4][CH2:3]2)=[O:35])[O:29][N:28]=1

参加物

4

反応物 3

HCID 883175-Amino-3,4-dimethylisoxazoleHCID 53485970Phenyl (3,4-dimethylisoxazol-5-yl)carbamateHCID 668761612-(3-(Piperidin-4-ylidenemethyl)phenoxy)-5-(trifluoromethyl)pyridine hydrochloride

生成物 1

HCID 24967635N-(3,4-dimethylisoxazol-5-yl)-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide

実験手順

Following the procedure in Example 1, Step 6, 2-(3-piperidin-4-ylidenemethyl-phenoxy)-5-trifluoromethyl-pyridine hydrochloride (150 mg, 0.40 mmol, from Example 1, Step 5) and phenyl 3,4-dimethylisoxazol-5-ylcarbamate (94 mg, 0.40 mmol, prepared according to the procedure described in Synthesis, 1997, 1189-1194 from 5-amino-3,4-dimethylisoxazole) were used to provide the title compound (187 mg). MS (APCI 10V) AP+ 473.3, AP− 471.2; 1H NMR (400 MHz, CD3OD) δ ppm 1.83 (s, 3H) 2.18 (s, 3H) 2.41-2.49 (m, 2H) 2.53-2.62 (m, 2H) 3.49-3.57 (m, 2H) 3.58-3.66 (m, 2H) 6.46 (s, 1H) 6.97-7.05 (m, 2H) 7.10-7.20 (m, 2H) 7.40 (tt, J=7.64, 0.76 Hz, 1H) 8.08 (dd, J=8.65, 2.51 Hz, 1H) 8.33-8.51 (m, J=2.31, 1.33, 0.88, 0.74 Hz, 1H).

後処理

  1. customprepared

出典と根拠

ORDレコード
ord-612b933f64ea4bfb9807f12da301a9b8
出典データセット
uspto-grants-2011_10
特許番号
US08044052B2

関連ノート

読み込み中…